Skip to main content

Hypoxemia in COVID-19: cerebral oximetry should be explored as a warning indicator for mechanically ventilated adults with COVID-19

Letter to the editor

We read with interest the review on the pathophysiology of ‘happy’ hypoxemia in COVID-19 by Dhont et al. published in BMC Respiratory Research [1]. This exhaustive review, describing the pathophysiological abnormalities in COVID-19 that might explain the disconnect between the severity of hypoxemia and the relatively mild respiratory discomfort reported by the patients, aims at improving decision-making and management among the physicians treating COVID-19. Very recent articles and reviews on the neurological manifestations of COVID-19 report patients with severe COVID-19 at risk for multifocal microvascular hemorrhagic and ischemic lesions [2,3,4,5,6,7]. Therefore, it would be very valuable to monitor the brain oxygenation state in mechanically ventilated patients with COVID-19.

In the last decades, brain oxygenation has been successfully monitored noninvasively and transcranially in the operative room and in the intensive care unit by commercial near-infrared spectroscopy (NIRS) brain oximeters [8,9,10,11]. These oximeters provide the intensivists with a continuous measure of the prefrontal cortex oxyhemoglobin saturation (ScO2, %). Unlike conventional fingertip pulse oximetry, ScO2 does not rely on a pulsating flow, and reflects the balance between oxygen supply and demand in the arteriolar, capillary and venular beds of the brain cortex underlying the prefrontal area over the sensor is located. Detailed cerebral oximetry guidelines have recently been drawn up by the Japanese Society of Cardiovascular Anesthesiologists [12].

To the best of our knowledge, so far the use of cerebral oximetry on ventilated COVID-19 patients has never been reported. In this framework, we suggest that the ScO2 monitoring in these patients might serve as an “early warning indicator” of the decreased brain oxygen delivery. The ScO2 data can be utilized to optimize cerebral oxygen supply and demand, inversing the decreased cerebral perfusion and/or preventing protracted brain ischemia.

Interestingly, cortical oximetry is utilized in an ongoing clinical trial of the Hvidovre University Hospital (Denmark) aiming to examine whether ScO2 could be a more useful parameter than peripheral arterial oxygen saturation, measured by fingertip pulse oximetry, to guide clinical titration of permissive hypoxemia in COVID-19 acute respiratory distress syndrome patients [13].

Availability of data and materials

Not applicable.

Abbreviations

NIRS:

Near-infrared spectroscopy

ScO2 :

Oxyhemoglobin saturation

References

  1. 1.

    Dhont S, Derom E, Van Braeckel E, Depuydt P, Lambrecht BN. The pathophysiology of ‘happy’ hypoxemia in COVID-19. Respir Res. 2020;21(1):198.

    CAS  Article  Google Scholar 

  2. 2.

    Ahmad I, Rathore FA. Neurological manifestations and complications of COVID-19: a literature review. J Clin Neurosci. 2020;77:8–12.

    CAS  Article  Google Scholar 

  3. 3.

    Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017–32.

    CAS  Article  Google Scholar 

  4. 4.

    Jaunmuktane Z, Mahadeva U, Green A, et al. Microvascular injury and hypoxic damage: emerging neuropathological signatures in COVID-19. Acta Neuropathol. 2020;140(3):397–400.

    CAS  Article  Google Scholar 

  5. 5.

    Kremer S, et al. Brain MRI findings in severe COVID-19: a retrospective observational study. Radiology. 2020:202222. https://doi.org/10.1148/radiol.2020202222.

  6. 6.

    Nepal G, Rehrig JH, Shrestha GS, Shing YK, Yadav JK, Ojha R, et al. Neurological manifestations of COVID-19: a systematic review. Crit Care. 2020;24(1):421.

    Article  Google Scholar 

  7. 7.

    Whittaker A, Anson M, Harky A. Neurological manifestations of COVID-19: a systematic review and current update. Acta Neurol Scand. 2020;142(1):14–22.

    CAS  Article  Google Scholar 

  8. 8.

    Benni PB, MacLeod D, Ikeda K, Lin HM. A validation method for near-infrared spectroscopy based tissue oximeters for cerebral and somatic tissue oxygen saturation measurements. J Clin Monit Comput. 2018;32(2):269–84.

    Article  Google Scholar 

  9. 9.

    Eyeington CT, Ancona P, Osawa EA, Cutuli SL, Eastwood GM, Bellomo R. Modern technology-derived normative values for cerebral tissue oxygen saturation in adults. Anaesth Intensive Care. 2019;47(1):69–75.

    Article  Google Scholar 

  10. 10.

    Ferrari M, Quaresima V. Review: near infrared brain and muscle oximetry: from the discovery to current applications. J Near Infrared Spectr. 2012;20(1):1–14.

    CAS  Article  Google Scholar 

  11. 11.

    Tosh W, Patteril M. Cerebral oximetry. BJA Educ. 2016;16(12):417–21.

    Article  Google Scholar 

  12. 12.

    Yoshitani K, Kawaguchi M, Ishida K, Maekawa K, Miyawaki H, Tanaka S, et al. Guidelines for the use of cerebral oximetry by near-infrared spectroscopy in cardiovascular anesthesia: a report by the cerebrospinal Division of the Academic Committee of the Japanese Society of Cardiovascular Anesthesiologists (JSCVA). J Anesth. 2019;33(2):167–96.

    Article  Google Scholar 

  13. 13.

    Clinical Trial: effects of cardiovascular and pulmonary optimization on cerebral oxygenation in COVID-19 patients with severe ARDS (NIRS-COV). ClinicalTrials.gov Identifier: NCT04392089. https://clinicaltrials.gov/ct2/show/NCT04392089. Accessed 24 Aug 2020.

Download references

Acknowledgements

Not applicable.

Funding

None.

Author information

Affiliations

Authors

Contributions

MF: drafted the letter, edited and reviewed the final submission. VQ: provided content input, critical feedback, edited and reviewed the final submission. The author(s) read and approved the final manuscript.

Corresponding author

Correspondence to Marco Ferrari.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

MF: no funding to declare or any conflicts of interest related to this work.

VQ: no funding to declare or any conflicts of interest related to this topic.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ferrari, M., Quaresima, V. Hypoxemia in COVID-19: cerebral oximetry should be explored as a warning indicator for mechanically ventilated adults with COVID-19. Respir Res 21, 261 (2020). https://doi.org/10.1186/s12931-020-01530-w

Download citation

Keywords

  • COVID-19
  • SARS-CoV-2
  • Respiratory failure
  • Hypoxemia
  • Cerebral oximetry
  • NIRS
  • Gas exchange